FATE THERAPEUTICS INC Public Float
FATE THERAPEUTICS INC (FATE) had Public Float of $113.00 million as of 2025-06-30, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-26
- 2025-06-30: Entity Public Float $113.00M.
- 2024-06-30: Entity Public Float $369.00M.
- 2023-06-30: Entity Public Float $462.00B.
- 2022-06-30: Entity Public Float $2.34T.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $113.00M 10-K · filed 2026-02-26 |
| 2024-06-30 | $369.00M 10-K · filed 2025-03-05 |
| 2023-06-30 | $462.00B 10-K · filed 2024-02-26 |
| 2022-06-30 | $2.34T 10-K · filed 2023-02-28 |
| 2021-06-30 | $6.96B 10-K · filed 2022-02-28 |
| 2020-06-30 | $2.49B 10-K · filed 2021-02-24 |
| 2019-06-28 | $1.06B 10-K · filed 2020-03-02 |
| 2018-06-30 | $488.65M 10-K · filed 2019-03-05 |
| 2017-06-30 | $122.33M 10-K · filed 2018-03-05 |
| 2016-06-30 | $43.69M 10-K · filed 2017-03-16 |
| 2015-06-30 | $166.23M 10-K · filed 2016-03-03 |
| 2014-06-30 | $111.54M 10-K · filed 2015-03-12 |
| 2013-12-31 | $0.00 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |